Learn / ACAD
NASDAQ: ACAD
Acadia Pharmaceuticals (ACAD) stock, explained like you're 5
Acadia Pharmaceuticals trades on the Nasdaq under the ticker ACAD. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.
- Ticker
- ACAD
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 3.4 billion dollars
Is Acadia Pharmaceuticals a small, medium or large cap company?
No. Acadia Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Acadia Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ACAD stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Acadia Pharmaceuticals (ACAD) Stock May Be Mispriced After Mixed Phase III Push (Simply Wall Street)
- UBS Downgrades ACADIA Pharmaceuticals to Neutral From Buy, $23 Price Target (Yahoo Finance)
- Acadia Pharmaceuticals stock hits 52 week low at 19.01 USD (Investing.com)
- ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts (Yahoo Finance)
- Did Raised Revenue Guidance Just Shift Acadia Pharmaceuticals (ACAD) Investment Narrative? (Simply Wall Street)
Follow ACAD in your daily brief
Each trading day at 5 PM ET we post what happened to Acadia Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ACAD
Questions about Acadia Pharmaceuticals stock
What does Acadia Pharmaceuticals do?
Acadia Pharmaceuticals trades on the Nasdaq under the ticker ACAD. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.
What is the ticker symbol for Acadia Pharmaceuticals?
Acadia Pharmaceuticals trades under the ticker ACAD on the Nasdaq.
What is Acadia Pharmaceuticals's market cap?
Acadia Pharmaceuticals is a mid cap stock with a market cap of about 3.4 billion dollars.
How does Acadia Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ACAD stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ACAD stock every day?
Add ACAD to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.